This Government Contract opportunity from Department Of Defense was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Manufacturing of FDA-Compliant Artificial Tears Solution

Closed

Federal

Submission Closed07/22/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Pharmaceutical Supply – Amlodipine Besylate TabletsThis subcontract with the Defense Logistics Agency under the Department of Defense involves the supply and delivery of Amlodipine Besylate Tablets. The contractor must ensure all products meet specific NDC and NSN 6505013675244 specifications and maintain full compliance with FDA current Good Manufacturing Practice regulations. The agreement is categorized under NAICS code 325412 for pharmaceutical manufacturing. All shipments are to be handled as FOB destination, and the contract is officially tracked under the award record associated with the Defense Logistics Agency.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Supply of Oseltamivir Phosphate (Tamiflu)This subcontract with the Defense Logistics Agency under the Department of Defense involves the procurement and delivery of 12,000 PG of Oseltamivir Phosphate, commonly known as Tamiflu. The scope of work encompasses the entire supply chain process, including the sourcing of the pharmaceutical, professional packaging, labeling, and final shipment to a designated military logistics facility. Classified under NAICS code 325412, the contract ensures the availability of critical antiviral medication for military use. The agreement is managed through the Defense Logistics Agency and follows specific federal procurement standards for pharmaceutical supply and distribution.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Product Supply – Bupivacaine Hydrochloride InjectionThis subcontract involves the manufacture and supply of Bupivacaine Hydrochloride Injection USP, 0.5%, in 50 mL quantities for the Department of Defense via the Medical Supply Chain Pharm FSA. The products must strictly adhere to FDA cGMP standards and meet specific packaging and labeling requirements, including MIL-STD-129, RP001, and DLA guidelines. The opportunity is categorized under NAICS code 325412. Interested parties must submit their responses by the deadline of August 24, 2026, following the posting date of August 17, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supply – Amlodipine Besylate TabletsThis subcontract involves the manufacture and supply of FDA-compliant generic Amlodipine Besylate Tablets for the Defense Logistics Agency under the Department of Defense. The contractor is required to adhere to current Good Manufacturing Practice standards to ensure the pharmaceutical products are suitable for delivery to a federal medical facility. The agreement is categorized under NAICS code 325412 for pharmaceutical preparation. It was posted on August 17, 2026, and is managed through the Defense Logistics Agency's procurement systems to support medical readiness and healthcare delivery within the federal system.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Product Supply – Diphenhydramine Hydrochloride InjectionThis subcontract, issued by the Defense Logistics Agency under the Department of Defense, involves the supply of one box of Diphenhydramine Hydrochloride Injection, identified by NSN 6505016490647. The product must comply with all applicable federal standards and be delivered to a designated military facility located in San Diego, California. The contract is categorized under NAICS code 325412 for pharmaceutical preparation. It was posted on August 17, 2026, and is managed through the DIBBS system under contract number SPE2DX25D9822.

Defense Logistics Agency

POSTED

DEADLINE

Manufacturing of Hemostatic DressingsThis subcontract involves the full-scale production of sterile hemostatic dressings composed of human fibrinogen, thrombin, and oxidized regenerated cellulose. The manufacturing process must strictly adhere to FDA and DLA standards to ensure medical compliance and safety. The project is managed by the Department of Defense under the Medical Supply Chain MD Surg FSF agency, with the place of performance located at Fort Bragg, ZIP code 28310. The solicitation was posted on August 17, 2026, and requires a response by August 24, 2026, falling under NAICS code 325412.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Epinephrine Injection (NDC 42023-0159-25)The Defense Logistics Agency, under the Department of Defense, has issued a subcontract for the supply and delivery of Epinephrine Injection. The required product is specified as 1 mg/mL in 30 x 1 mL vials per unit of issue, identified by NDC 42023-0159-25. All deliverables must strictly comply with FDA, DEA, and cGMP standards to ensure pharmaceutical quality and regulatory adherence. This procurement falls under NAICS code 325412 and was posted on August 17, 2026. The contract is managed through the Defense Logistics Agency's procurement systems, focusing on the consistent provision of critical medical supplies for military and governmental use.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Supply – Omeprazole CapsulesThis subcontract involves the supply and delivery of four units of Omeprazole Extended-Release Capsules, 20 mg, for the Department of Defense through the Medical Supply Chain Pharm FSA. The pharmaceutical products must strictly adhere to FDA, DLA, and military medical standards regarding regulatory requirements, labeling, and packaging. The contract is categorized under NAICS code 325412 and is to be performed at Fort Bliss, Texas. Interested parties must submit their responses by August 24, 2026, following the posting date of August 17, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Medical Reagent Supply – Fluoride Water Sampling Test KitsThis subcontract opportunity with the Department of Defense Medical Supply Chain FSH involves the procurement of FDA-compliant, medical-grade water sampling test reagents specifically designed for fluoride detection. All supplied items must be sealed and shelf-stable, with a strict delivery requirement of 20 days following the receipt of the order. The contract is categorized under NAICS code 325412 and will be performed at Davis Monthan AFB in Arizona. Interested parties must submit their responses by the deadline of August 24, 2026.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Pharmaceutical Supply – Haloperidol Injection and Similar NDC ItemsThis subcontract with the Defense Logistics Agency under the Department of Defense involves the supply of FDA-approved Haloperidol Injection and other specific NDC pharmaceuticals. The scope of work includes the provision of packaging, labeling, and strict adherence to regulatory compliance standards to ensure all items are delivered according to DLA contract requirements. Classified under NAICS code 325412, the agreement focuses on the procurement and delivery of specialized pharmaceutical products. The contract was posted on August 17, 2026, and is managed through the Defense Logistics Agency's procurement systems.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Manufacturing – Sterile Injectable SolutionsThis subcontract opportunity with the Department of Defense, managed by the Medical Supply Chain Pharm FSA, involves the manufacture of sterile Sodium Chloride Injection 0.9%. The required product consists of 100 mL doses provided in 150 mL fill plastic containers, with production must adhere to FDA cGMP, USP 797, and specific military shelf-life standards. The project falls under NAICS code 325412 and is designated for performance at Fort Bragg, ZIP code 28310. Interested parties must submit their responses by the deadline of August 24, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing – Benzonatate CapsulesThis subcontract involves the pharmaceutical manufacturing of 100 mg benzonatate capsules for the Department of Defense, specifically through the Medical Supply Chain Pharm FSA. The contractor is required to produce the medication in 100-count bottles that strictly adhere to FDA compliance, USP standards, and DLA technical requirements. The opportunity was posted on August 17, 2026, with a response deadline of August 24, 2026. Classified under NAICS code 325412, this procurement focuses on the production of pharmaceutical preparations to meet specific military medical supply chain needs.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days

AI Contract Overview

The contract entails the manufacturing of a sterile ophthalmic artificial tears solution packaged in single-dose containers, adhering strictly to FDA regulations, current Good Manufacturing Practices, and military packaging standards. The product must meet stringent quality and safety requirements to ensure suitability for use by military personnel and in operational environments, with all production processes fully compliant with cGMP guidelines to guarantee consistency, sterility, and efficacy. The solution is intended for distribution through the Department of Defense supply chain, specifically under the Medical Supply Chain Pharm FSA, and must be produced to support the needs of military medical facilities. Performance is required at Fort Stewart, Georgia, with the delivery deadline aligned to the contract's response deadline of July 22, 2026. This is a subcontract opportunity classified under NAICS code 325412 for pharmaceutical preparation manufacturing, and while no set-aside provisions are indicated, participation is open to qualified manufacturers capable of meeting the technical, regulatory, and logistical demands of a defense-related pharmaceutical supply contract. All work must be completed in compliance with federal and military specifications, and bidders are expected to demonstrate proven experience in sterile pharmaceutical production and the ability to adhere to strict documentation and inspection protocols.